Professor Sir Peng Tee Khaw is Professor of Glaucoma and Ocular Healing at the UCL Institute of Ophthalmology and Consultant Ophthalmic Surgeon at Moorfields Eye Hospital, London UK. He is also Director of the National Institute for Health Research Specialist Biomedical Research Centre in Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology; Director of Research and Development at Moorfields Eye Hospital; President of the UK Paediatric Glaucoma Society; and an NIHR Senior Investigator since 2009.
Professor Sir Peng Tee Khaw has a special interest in the surgical and medical treatment of the refractory glaucomas, particularly paediatric glaucoma. His group undertakes research into new surgical techniques and new treatments to prevent scarring and encourage regeneration of tissues after ocular surgery and disease. They have developed inexpensive single applications of intra-operative antimetabolites that have been tested in clinical trials across the world, and have also developed new surgical techniques, including the Moorfields Safer Surgery System, dramatically reducing bleb related and other complications, now used worldwide. They are developing drug delivery systems, stem cell therapies and new single application anti-scarring treatments.
Professor Sir Peng Tee Khaw has delivered over 35 national and international named lectures, won over 12 prizes & awards including the first international ARVO Pfizer Translational Medicine Prize. He was the first UK President of the Association for Research in Vision and Ophthalmology (ARVO, 2012-2013). He has raised grants of over £120 million, including funding for the world’s largest Children’s Eye Hospital and translational research clinical centre, and was knighted in the Queen’s Birthday Honours for 2013 for services to ophthalmology, one of two ophthalmologists in the last century. He passionately believes that scientific research will enable us to achieve new and better treatments to changes lives for the better.